Compare SNY & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNY | SBUX |
|---|---|---|
| Founded | 1994 | 1971 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5B | 122.1B |
| IPO Year | 2001 | 1994 |
| Metric | SNY | SBUX |
|---|---|---|
| Price | $42.67 | $98.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 29 |
| Target Price | $58.00 | ★ $104.39 |
| AVG Volume (30 Days) | 2.1M | ★ 5.2M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.47% | 2.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.62 |
| Revenue | N/A | ★ $37,184,400,000.00 |
| Revenue This Year | $3.49 | $4.88 |
| Revenue Next Year | $6.10 | $5.15 |
| P/E Ratio | ★ $6.14 | $61.75 |
| Revenue Growth | N/A | ★ 2.79 |
| 52 Week Low | $40.89 | $77.99 |
| 52 Week High | $52.68 | $110.51 |
| Indicator | SNY | SBUX |
|---|---|---|
| Relative Strength Index (RSI) | 35.88 | 32.44 |
| Support Level | $42.30 | $96.45 |
| Resistance Level | $45.22 | $101.18 |
| Average True Range (ATR) | 0.59 | 2.28 |
| MACD | -0.30 | -0.94 |
| Stochastic Oscillator | 1.89 | 2.61 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.